TMEM212
gene geneOn this page
Also known as FLJ23172
Summary
TMEM212 (transmembrane protein 212, HGNC:34295) is a protein-coding gene on chromosome 3q26.31, encoding Transmembrane protein 212 (A6NML5).
Predicted to be located in membrane.
Source: NCBI Gene 389177 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 28 total
- MANE Select transcript:
NM_001164436
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34295 |
| Approved symbol | TMEM212 |
| Name | transmembrane protein 212 |
| Location | 3q26.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23172 |
| Ensembl gene | ENSG00000186329 |
| Ensembl biotype | protein_coding |
| Entrez | 389177 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000334567, ENST00000420375, ENST00000450693, ENST00000469981, ENST00000619900, ENST00000905715
RefSeq mRNA: 1 — MANE Select: NM_001164436
NM_001164436
CCDS: CCDS46958
Canonical transcript exons
ENST00000334567 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001338950 | 171851982 | 171852041 |
| ENSE00001338953 | 171853527 | 171853850 |
| ENSE00001338957 | 171843349 | 171843542 |
| ENSE00001530051 | 171858061 | 171859318 |
| ENSE00001530052 | 171856663 | 171856707 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 97.09.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0454 / max 25.6867, expressed in 12 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 39801 | 0.0454 | 12 |
Top tissues by expression
196 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 97.09 | gold quality |
| bronchial epithelial cell | CL:0002328 | 93.05 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 91.27 | gold quality |
| bronchus | UBERON:0002185 | 90.69 | gold quality |
| right uterine tube | UBERON:0001302 | 89.94 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 87.95 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 85.05 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.67 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 83.13 | gold quality |
| cerebellar vermis | UBERON:0004720 | 82.20 | silver quality |
| pancreatic ductal cell | CL:0002079 | 79.93 | silver quality |
| sperm | CL:0000019 | 79.53 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 78.81 | gold quality |
| male germ cell | CL:0000015 | 78.12 | silver quality |
| medial globus pallidus | UBERON:0002477 | 77.35 | silver quality |
| globus pallidus | UBERON:0001875 | 76.91 | silver quality |
| gluteal muscle | UBERON:0002000 | 76.90 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 76.51 | gold quality |
| vena cava | UBERON:0004087 | 76.22 | silver quality |
| pylorus | UBERON:0001166 | 76.18 | silver quality |
| cardia of stomach | UBERON:0001162 | 76.13 | silver quality |
| nipple | UBERON:0002030 | 76.03 | silver quality |
| endothelial cell | CL:0000115 | 75.76 | silver quality |
| tongue squamous epithelium | UBERON:0006919 | 75.17 | silver quality |
| inferior vagus X ganglion | UBERON:0005363 | 74.94 | silver quality |
| superior surface of tongue | UBERON:0007371 | 74.94 | silver quality |
| subthalamic nucleus | UBERON:0001906 | 74.86 | silver quality |
| ventral tegmental area | UBERON:0002691 | 74.85 | silver quality |
| pericardium | UBERON:0002407 | 74.83 | silver quality |
| fallopian tube | UBERON:0003889 | 74.59 | gold quality |
Single-cell (SCXA)
Detected in 11 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-137537 | yes | 1041.48 |
| E-CURD-89 | yes | 250.82 |
| E-MTAB-5061 | yes | 14.68 |
| E-ANND-3 | yes | 7.90 |
| E-CURD-53 | no | 553.34 |
| E-MTAB-10290 | no | 164.64 |
| E-MTAB-7249 | no | 96.91 |
| E-ENAD-20 | no | 63.12 |
| E-GEOD-99795 | no | 14.09 |
| E-GEOD-81547 | no | 4.80 |
| E-CURD-112 | no | 2.63 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
69 targeting TMEM212, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-371A-3P | 99.99 | 66.77 | 91 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-767-5P | 99.95 | 70.85 | 993 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-10395-5P | 99.86 | 67.35 | 676 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-578 | 99.46 | 68.36 | 1787 |
| HSA-MIR-6513-5P | 99.43 | 67.81 | 1071 |
| HSA-MIR-889-5P | 99.41 | 68.75 | 1025 |
| HSA-MIR-7151-5P | 99.37 | 67.82 | 613 |
| HSA-MIR-135A-5P | 99.36 | 71.85 | 1601 |
| HSA-MIR-542-3P | 99.34 | 67.58 | 1270 |
| HSA-MIR-4312 | 99.34 | 67.30 | 511 |
| HSA-MIR-4796-5P | 99.34 | 70.06 | 810 |
| HSA-MIR-148A-5P | 99.30 | 68.27 | 1141 |
| HSA-MIR-133A-3P | 99.27 | 71.53 | 1270 |
| HSA-MIR-133B | 99.27 | 71.53 | 1270 |
Literature-anchored findings (GeneRIF, showing 1)
- The specialized function of this brain region suggests that TMEM212 could contribute to the innate architecture of face processing. (PMID:22828495)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem212 | ENSMUSG00000043164 |
| rattus_norvegicus | Tmem212 | ENSRNOG00000012608 |
Paralogs (16): MS4A12 (ENSG00000071203), MS4A6A (ENSG00000110077), MS4A4A (ENSG00000110079), MS4A3 (ENSG00000149516), MS4A2 (ENSG00000149534), MS4A1 (ENSG00000156738), MS4A6E (ENSG00000166926), MS4A7 (ENSG00000166927), MS4A14 (ENSG00000166928), MS4A5 (ENSG00000166930), MS4A8 (ENSG00000166959), MS4A15 (ENSG00000166961), MS4A10 (ENSG00000172689), MS4A13 (ENSG00000204979), MS4A18 (ENSG00000214782), MS4A4E (ENSG00000214787)
Protein
Protein identifiers
Transmembrane protein 212 — A6NML5 (reviewed: A6NML5)
All UniProt accessions (3): A6NML5, H7C098, H7C390
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_001157908* (*=MANE)
Domains & families (InterPro)
UniProt features (6 total): transmembrane region 5, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NML5-F1 | 74.31 | 0.31 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 59 (showing top):
XU_GH1_AUTOCRINE_TARGETS_UP, chr3q26, HARRIS_BRAIN_CANCER_PROGENITORS, JAK2_DN.V1_DN, GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN, FOXJ2_TARGET_GENES, ZNF274_TARGET_GENES, MIR8068, MIR578, MIR4782_5P, MIR5706, MIR6740_3P, MIR4424, MIR148A_5P, MIR6513_5P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
636 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM212 | LINC03043 | A4D0Y5 | 505 |
| TMEM212 | TMEM221 | A6NGB7 | 470 |
| TMEM212 | TCF12 | Q99081 | 450 |
| TMEM212 | CFAP20DC | Q6ZVT6 | 447 |
| TMEM212 | TSPAN19 | P0C672 | 441 |
| TMEM212 | PLEKHN1 | Q494U1 | 435 |
| TMEM212 | SLC24A3 | Q9HC58 | 428 |
| TMEM212 | ZNF396 | Q96N95 | 420 |
| TMEM212 | FAM216B | Q8N7L0 | 414 |
| TMEM212 | SPATA18 | Q8TC71 | 407 |
| TMEM212 | SNTN | A6NMZ2 | 407 |
| TMEM212 | DYNLT4 | Q5JR98 | 403 |
| TMEM212 | DYNLRB2 | Q8TF09 | 403 |
| TMEM212 | PTPDC1 | A2A3K4 | 399 |
| TMEM212 | MFAP3 | P55082 | 397 |
IntAct
0 interactions, top by confidence:
BioGRID (2): TMEM212 (Affinity Capture-RNA), TMEM212 (Protein-RNA)
ESM2 similar proteins: A4IIU3, A6NML5, D3YWQ9, O75204, P0DP42, P11836, P20490, P56749, Q01362, Q0IIL2, Q2KJ11, Q2YDM3, Q32KQ5, Q3T110, Q3YBM2, Q497B3, Q4G068, Q504G0, Q5EB63, Q5FWC3, Q5HYL7, Q5M962, Q5R8D6, Q5R9K1, Q5RCD5, Q5RFC1, Q6GV28, Q7T392, Q7TQI0, Q7YQI4, Q8BGP5, Q8BHH8, Q8C6V3, Q8K177, Q8NCR9, Q8VHW1, Q8WXS4, Q920C4, Q925D4, Q940P5
Diamond homologs: A6NML5, Q8C6V3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
28 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
459 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:171843439:GT:G | donor_gain | 0.9900 |
| 3:171853851:G:GG | donor_gain | 0.9800 |
| 3:171843499:G:GT | donor_gain | 0.9400 |
| 3:171852108:G:GT | donor_gain | 0.9400 |
| 3:171843450:G:GT | donor_gain | 0.9300 |
| 3:171851271:G:GT | donor_gain | 0.9300 |
| 3:171845754:TCAA:T | donor_gain | 0.9200 |
| 3:171843535:GAGCT:G | donor_gain | 0.9100 |
| 3:171853521:TTTCA:T | acceptor_loss | 0.9100 |
| 3:171853522:TTCA:T | acceptor_loss | 0.9100 |
| 3:171853523:TCAGG:T | acceptor_loss | 0.9100 |
| 3:171853524:CAGGG:C | acceptor_loss | 0.9100 |
| 3:171853526:G:GA | acceptor_loss | 0.9100 |
| 3:171853850:CGTAA:C | donor_loss | 0.9100 |
| 3:171853851:GTA:G | donor_loss | 0.9100 |
| 3:171853852:TAAG:T | donor_loss | 0.9100 |
| 3:171853853:A:AG | donor_loss | 0.9100 |
| 3:171853854:AGTTT:A | donor_loss | 0.9100 |
| 3:171843543:G:GG | donor_gain | 0.9000 |
| 3:171852046:A:G | donor_gain | 0.9000 |
| 3:171853525:AG:A | acceptor_gain | 0.9000 |
| 3:171853526:GG:G | acceptor_gain | 0.9000 |
| 3:171843540:TTG:T | donor_loss | 0.8900 |
| 3:171843541:TGG:T | donor_loss | 0.8900 |
| 3:171843542:GGTA:G | donor_loss | 0.8900 |
| 3:171843543:G:T | donor_loss | 0.8900 |
| 3:171843544:T:A | donor_loss | 0.8900 |
| 3:171853855:G:C | donor_loss | 0.8900 |
| 3:171853525:AGG:A | acceptor_gain | 0.8700 |
| 3:171853526:GGG:G | acceptor_gain | 0.8700 |
AlphaMissense
1237 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:171853773:A:C | S156R | 0.922 |
| 3:171853775:C:A | S156R | 0.922 |
| 3:171853775:C:G | S156R | 0.922 |
| 3:171843438:A:C | S19R | 0.914 |
| 3:171843440:T:A | S19R | 0.914 |
| 3:171843440:T:G | S19R | 0.914 |
| 3:171843492:T:C | F37L | 0.914 |
| 3:171843494:C:A | F37L | 0.914 |
| 3:171843494:C:G | F37L | 0.914 |
| 3:171843462:T:C | F27L | 0.911 |
| 3:171843464:C:A | F27L | 0.911 |
| 3:171843464:C:G | F27L | 0.911 |
| 3:171853557:A:C | S84R | 0.911 |
| 3:171853559:C:A | S84R | 0.911 |
| 3:171853559:C:G | S84R | 0.911 |
| 3:171843465:T:C | F28L | 0.859 |
| 3:171843467:T:A | F28L | 0.859 |
| 3:171843467:T:G | F28L | 0.859 |
| 3:171843504:A:C | S41R | 0.856 |
| 3:171843506:T:A | S41R | 0.856 |
| 3:171843506:T:G | S41R | 0.856 |
| 3:171843528:T:A | W49R | 0.851 |
| 3:171843528:T:C | W49R | 0.851 |
| 3:171843485:G:C | K34N | 0.847 |
| 3:171843485:G:T | K34N | 0.847 |
| 3:171843429:G:T | G16W | 0.834 |
| 3:171843429:G:A | G16R | 0.825 |
| 3:171843429:G:C | G16R | 0.825 |
| 3:171853569:T:C | C88R | 0.811 |
| 3:171853581:T:C | F92L | 0.808 |
dbSNP variants (sampled 300 via entrez): RS1000143828 (3:171847927 T>C), RS1000253748 (3:171844978 G>A), RS1000306591 (3:171859196 T>C), RS1000533364 (3:171852929 G>A), RS1000790234 (3:171847441 T>C,G), RS1000810723 (3:171855445 T>A), RS1000946279 (3:171855069 T>C), RS1001049716 (3:171853173 C>A), RS1001139185 (3:171851173 A>G), RS1001226342 (3:171845066 C>T), RS1001275101 (3:171850854 C>T), RS1001367436 (3:171849950 C>G), RS1001437435 (3:171843511 G>A,C,T), RS1001483704 (3:171857006 T>C), RS1002158597 (3:171845422 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000821_15 | Bipolar disorder and schizophrenia | 6.000000e-07 |
| GCST001125_1 | Body mass index | 2.000000e-06 |
| GCST001520_6 | Response to angiotensin II receptor blocker therapy | 4.000000e-07 |
| GCST003059_6 | Parkinson’s disease | 1.000000e-06 |
| GCST006138_39 | Resting-state electroencephalogram vigilance | 2.000000e-06 |
| GCST011390_2 | Corneal resistance factor | 5.000000e-66 |
| GCST011946_25 | White matter hyperintensity volume | 1.000000e-05 |
| GCST011947_9 | White matter hyperintensity volume | 4.000000e-06 |
| GCST011949_42 | White matter hyperintensity volume (adjusted for hypertension) | 4.000000e-06 |
| GCST011950_37 | White matter hyperintensity volume (adjusted for hypertension) | 2.000000e-06 |
| GCST011952_26 | White matter hyperintensity volume x hypertension interaction (2df) | 6.000000e-06 |
| GCST011953_19 | White matter hyperintensity volume x hypertension interaction (2df) | 3.000000e-06 |
| GCST90013442_5 | Keratoconus | 1.000000e-26 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004357 | electroencephalogram measurement |
| EFO:0010067 | corneal resistance factor |
| EFO:0005665 | white matter hyperintensity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases expression, increases abundance | 2 |
| fipronil | decreases expression, affects cotreatment | 1 |
| jinfukang | decreases expression | 1 |
| Decitabine | increases expression | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mental disorder